revealed that apelin-13 promoted lung adenocarcinoma cells migration by phosphorylating p21-activated kinase (PAK) 1 and cofilin, suggesting that apelin/APJ and downstream signaling may be potential therapeutic targets for anti-metastasis in patients with lung adenocarcinoma (39). This evidence concerns the gene APLN and lung adenocarcinoma.